Table 5.
Number of postremission courses completed by randomized arm
| HiDAC alone, no. (%) | MCT, no. (%) | Total, no. (%) | |
|---|---|---|---|
| Courses completed | |||
| 1 | 151 (99) | 155 (99) | 306 (99) |
| 1 and 2 | 134 (88) | 145 (93) | 279 (91) |
| 1, 2, and 3 | 118 (78) | 120 (77) | 238 (77) |
| Reasons for not completing all 3 courses | |||
| Relapse | 12 | 11 | 23 |
| Withdrawn | 3 | 7 | 10 |
| Slow recovery of counts | 3 | 5 | 8 |
| Toxicity | 3 | 4 | 7 |
| Infection | |||
| Neurologic | 5 | 0 | 5 |
| BMT | 4 | 2 | 6 |
| Death | 3 | 3 | 6 |
| Refused | 0 | 3 | 3 |
| Wrong treatment | 1 | 0 | 1 |
| Other disease | 0 | 1 | 1 |
| Total | 34 | 36 | 70 |
For HiDAC alone, there were 152 evaluable patients; for MCT, 156; and for total, 308.
BMT indicates bone marrow transplantation.